AstraZeneca cancer drug trial shows improved overall survival rate Read More
LONDON BROKER RATINGS: Upgrades for Pearson; Berenberg cuts IAG, Wizz Read More
TOP NEWS: AstraZeneca urges shareholders to veto TRC mini-tender offer Read More
LONDON BRIEFING: Playtech accepts GBP2 billion Australian takeover Read More
AstraZeneca says Imfinzi combination drug boosts liver cancer survival Read More
European drug watchdog reviews AstraZeneca anti-Covid cocktail Read More
LONDON MARKET CLOSE: Stocks mixed as oil majors, miners lift FTSE 100 Read More
LONDON BROKER RATINGS: Berenberg starts Dunelm and Wickes at Buy Read More
TOP NEWS: AstraZeneca gets positive results from Covid-19 drug trial Read More
LONDON MARKET PRE-OPEN: ASOS CEO to leave; warns on profit amid costs Read More
AstraZeneca seeks emergency FDA approval for drug preventing Covid Read More
AstraZeneca breast cancer drug gets breakthrough therapy designation Read More
LONDON MARKET CLOSE: Next upgrade, weaker pound help FTSE 100 rebound Read More
LONDON MARKET MIDDAY: Stocks rise as Evergrande fears ease, weak pound Read More
AstraZeneca to buy out Caelum Biosciences for up to USD500 million Read More
LONDON MARKET OPEN: AstraZeneca and Next lead FTSE 100 higher Read More
AstraZeneca autoimmune treatment Saphnelo approved in Japan Read More
LONDON MARKET MIDDAY: Stocks fall as Evergrande silence sparks fear Read More
LONDON MARKET OPEN: JD Sports falls after Nike cuts revenue forecast Read More
AstraZeneca's Lynparza meets primary endpoint in prostate cancer trial Read More
